Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Deichmann

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Melanoma Research|November 30, 2005
Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanomaSabine Brennecke, Martin Deichmann, Helmut Naeher, et al.
Oncology|August 28, 2004
B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcomeMartin Deichmann, Marianne Thome, Axel Benner, et al.
Archives of Dermatological Research|July 5, 2003
Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapyHjalmar Kurzen, Sepp Kaul, Ursel Egner, et al.
Journal of Cutaneous Pathology|July 2, 2003
Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas)Martin Deichmann, Hjalmar Kurzen, Ursula Egner, et al.
Journal of Cutaneous Pathology|July 13, 2005
The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skinMartin Deichmann, Marianne Thome, Ursula Egner, et al.
BMC Cancer|June 7, 2005
Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastasesMartin Deichmann, Marianne Thome, Axel Benner, et al.
International Journal of Oncology|June 15, 2006
The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sitesMartin Deichmann, Dieter Krahl, Marianne Thome, et al.
Melanoma Research|September 24, 2005
Preponderance of the oncogenic V599E and V599K mutations in the B-raf kinase domain is enhanced in melanoma lymph node metastasesMartin Kirschner, Burkhard Helmke, Hans Starz, et al.
International Journal of Oncology|December 5, 2003
Somatic mitochondrial mutations in melanoma resection specimensMartin Deichmann, Birgit Kahle, Axel Benner, et al.
Archives of Dermatological Research|January 5, 2005
Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminantMartin Deichmann, Jon B Huder, Christian Kleist, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Melanoma Research|November 30, 2005
Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanomaSabine Brennecke, Martin Deichmann, Helmut Naeher, et al.
Oncology|August 28, 2004
B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcomeMartin Deichmann, Marianne Thome, Axel Benner, et al.
Archives of Dermatological Research|July 5, 2003
Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapyHjalmar Kurzen, Sepp Kaul, Ursel Egner, et al.
Journal of Cutaneous Pathology|July 2, 2003
Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas)Martin Deichmann, Hjalmar Kurzen, Ursula Egner, et al.
Journal of Cutaneous Pathology|July 13, 2005
The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skinMartin Deichmann, Marianne Thome, Ursula Egner, et al.
BMC Cancer|June 7, 2005
Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastasesMartin Deichmann, Marianne Thome, Axel Benner, et al.
International Journal of Oncology|June 15, 2006
The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sitesMartin Deichmann, Dieter Krahl, Marianne Thome, et al.
Melanoma Research|September 24, 2005
Preponderance of the oncogenic V599E and V599K mutations in the B-raf kinase domain is enhanced in melanoma lymph node metastasesMartin Kirschner, Burkhard Helmke, Hans Starz, et al.
International Journal of Oncology|December 5, 2003
Somatic mitochondrial mutations in melanoma resection specimensMartin Deichmann, Birgit Kahle, Axel Benner, et al.
Archives of Dermatological Research|January 5, 2005
Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminantMartin Deichmann, Jon B Huder, Christian Kleist, et al.
Pageof 2